Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000312789 | SCV000400911 | benign | Common Variable Immune Deficiency, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000455556 | SCV000540556 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
ARUP Laboratories, |
RCV001540627 | SCV000605397 | benign | not provided | 2019-11-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001520146 | SCV001729185 | benign | Immunodeficiency, common variable, 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001540627 | SCV001758529 | benign | not provided | 2018-11-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28728263) |
Unidad de Genómica Garrahan, |
RCV000455556 | SCV004233660 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 29% of patients studied by a panel of primary immunodeficiencies. Number of patients: 28. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001540627 | SCV005248021 | benign | not provided | criteria provided, single submitter | not provided |